| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |